Glaxo Smith Kline (BIOC)

Last update: 14 January 02:14 PM market time.

60.08

-1.46

-2.37%

Open 61.54

Previous Close 61.54

High 62.34

Low 60.00

Stock Statistics

Volume 24,117

Turnover 1,465,780.88

All data are 15 minutes late during market session

Announcements

6 January 03:47 PM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers

4 January 10:00 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

30 December 2025 11:20 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Declares Cash Dividends

18 November 2025 10:25 AM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the Board of Directors & the Executive Managers

4 November 2025 03:39 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - AGM Minutes (after Certification)

12 August 2025 10:21 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Consolidated Results

12 August 2025 09:46 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Standalone Results

12 August 2025 09:44 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

27 July 2025 03:09 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

14 May 2025 09:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

5 May 2025 03:28 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form concerning the BoD & the Shareholders' Structure

4 May 2025 03:06 PM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the AGM

9 March 2025 10:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2024 Consolidated Results

9 March 2025 10:20 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

15 January 2025 04:17 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

14 November 2024 03:01 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 9 Months Standalone Results

14 November 2024 11:07 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

14 November 2024 11:03 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 9 Months Consolidated Results

15 October 2024 08:52 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

15 August 2024 09:18 AM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the BoD & the Executive Managers

14 August 2024 09:26 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Consolidated Results

14 August 2024 09:22 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions